Roffman Miller Associates Inc. PA decreased its holdings in shares of Colgate-Palmolive (NYSE:CL – Free Report) by 8.5% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 18,514 shares of the company’s stock after selling 1,722 shares during the quarter. Roffman Miller Associates Inc. PA’s holdings in Colgate-Palmolive were worth $1,683,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. State Street Corp raised its position in shares of Colgate-Palmolive by 3.8% during the third quarter. State Street Corp now owns 48,436,276 shares of the company’s stock valued at $5,028,170,000 after buying an additional 1,784,411 shares during the last quarter. Geode Capital Management LLC increased its stake in Colgate-Palmolive by 2.8% during the third quarter. Geode Capital Management LLC now owns 20,193,331 shares of the company’s stock valued at $2,095,325,000 after acquiring an additional 552,949 shares during the period. Massachusetts Financial Services Co. MA raised its holdings in Colgate-Palmolive by 6.2% in the 3rd quarter. Massachusetts Financial Services Co. MA now owns 9,526,990 shares of the company’s stock valued at $988,997,000 after acquiring an additional 557,492 shares in the last quarter. Barclays PLC lifted its position in shares of Colgate-Palmolive by 38.7% in the 3rd quarter. Barclays PLC now owns 7,644,189 shares of the company’s stock worth $793,542,000 after acquiring an additional 2,132,747 shares during the period. Finally, FMR LLC grew its holdings in shares of Colgate-Palmolive by 65.6% during the 3rd quarter. FMR LLC now owns 6,749,275 shares of the company’s stock worth $700,642,000 after purchasing an additional 2,674,807 shares in the last quarter. Institutional investors and hedge funds own 80.41% of the company’s stock.
Analyst Ratings Changes
CL has been the subject of several research reports. Royal Bank of Canada reaffirmed a “sector perform” rating and issued a $101.00 target price on shares of Colgate-Palmolive in a research report on Wednesday, January 29th. Barclays reduced their price objective on shares of Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating for the company in a report on Friday, January 17th. TD Cowen lowered their target price on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating on the stock in a research note on Wednesday, January 8th. JPMorgan Chase & Co. dropped their price target on shares of Colgate-Palmolive from $103.00 to $97.00 and set an “overweight” rating for the company in a research report on Monday, February 3rd. Finally, Morgan Stanley decreased their price objective on Colgate-Palmolive from $111.00 to $104.00 and set an “overweight” rating on the stock in a report on Monday, February 3rd. One research analyst has rated the stock with a sell rating, ten have assigned a hold rating and twelve have given a buy rating to the stock. According to MarketBeat.com, Colgate-Palmolive presently has a consensus rating of “Hold” and an average target price of $101.16.
Colgate-Palmolive Stock Performance
CL stock opened at $89.56 on Monday. The stock has a market capitalization of $72.68 billion, a PE ratio of 25.44, a price-to-earnings-growth ratio of 4.20 and a beta of 0.44. The company has a debt-to-equity ratio of 13.40, a current ratio of 0.92 and a quick ratio of 0.58. The company has a 50 day moving average price of $88.94 and a 200 day moving average price of $95.82. Colgate-Palmolive has a fifty-two week low of $84.45 and a fifty-two week high of $109.30.
Colgate-Palmolive (NYSE:CL – Get Free Report) last issued its quarterly earnings results on Friday, January 31st. The company reported $0.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same quarter last year, the firm earned $0.87 EPS. Analysts forecast that Colgate-Palmolive will post 3.75 EPS for the current year.
Colgate-Palmolive Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st were given a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 2.23%. The ex-dividend date of this dividend was Tuesday, January 21st. Colgate-Palmolive’s dividend payout ratio is 56.82%.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Recommended Stories
- Five stocks we like better than Colgate-Palmolive
- What is the MACD Indicator and How to Use it in Your Trading
- Why Genuine Parts Company Is a Royally Good Buy Right Now
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Industrials Are Quietly Outpacing the Market: 3 Stocks to Watch
- What is the Nikkei 225 index?
- These 5 Energy Stocks Hedge Inflation With Growth Potential
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.